vs

Side-by-side financial comparison of IMMUCELL CORP (ICCC) and NUSCALE POWER Corp (SMR). Click either name above to swap in a different company.

NUSCALE POWER Corp is the larger business by last-quarter revenue ($8.2M vs $5.5M, roughly 1.5× IMMUCELL CORP). IMMUCELL CORP runs the higher net margin — -2.5% vs -3316.2%, a 3313.6% gap on every dollar of revenue. On growth, NUSCALE POWER Corp posted the faster year-over-year revenue change (1635.2% vs -8.4%). IMMUCELL CORP produced more free cash flow last quarter ($-1.8M vs $-199.9M). Over the past eight quarters, NUSCALE POWER Corp's revenue compounded faster (22.4% CAGR vs 3.9%).

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

NuScale Power Corporation is a publicly traded American company that designs and markets small modular reactors (SMRs). It is headquartered in Tigard, Oregon. The company's VOYGR power plant, which uses 50 MWe modules and scales to 12 modules, was the first SMR to be certified by the US Nuclear Regulatory Commission (NRC) (2022). The newer 77 MWe module designs, known as the VOYGR-4 and VOYGR-6, were submitted for NRC review on January 1, 2023, and approved May 29, 2025. NuScale is now seekin...

ICCC vs SMR — Head-to-Head

Bigger by revenue
SMR
SMR
1.5× larger
SMR
$8.2M
$5.5M
ICCC
Growing faster (revenue YoY)
SMR
SMR
+1643.6% gap
SMR
1635.2%
-8.4%
ICCC
Higher net margin
ICCC
ICCC
3313.6% more per $
ICCC
-2.5%
-3316.2%
SMR
More free cash flow
ICCC
ICCC
$198.1M more FCF
ICCC
$-1.8M
$-199.9M
SMR
Faster 2-yr revenue CAGR
SMR
SMR
Annualised
SMR
22.4%
3.9%
ICCC

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
ICCC
ICCC
SMR
SMR
Revenue
$5.5M
$8.2M
Net Profit
$-139.7K
$-273.3M
Gross Margin
42.9%
32.9%
Operating Margin
0.4%
-6532.9%
Net Margin
-2.5%
-3316.2%
Revenue YoY
-8.4%
1635.2%
Net Profit YoY
80.1%
-1465.5%
EPS (diluted)
$-0.02
$-1.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICCC
ICCC
SMR
SMR
Q3 25
$5.5M
$8.2M
Q2 25
$6.4M
$8.1M
Q1 25
$8.1M
$13.4M
Q4 24
$7.8M
$34.2M
Q3 24
$6.0M
Q2 24
$5.5M
Q1 24
$7.3M
Q4 23
$5.1M
$4.6M
Net Profit
ICCC
ICCC
SMR
SMR
Q3 25
$-139.7K
$-273.3M
Q2 25
$501.9K
$-17.6M
Q1 25
$1.4M
$-14.0M
Q4 24
$-75.0M
Q3 24
$-701.7K
Q2 24
$-1.5M
Q1 24
$-437.9K
Q4 23
$-18.8M
Gross Margin
ICCC
ICCC
SMR
SMR
Q3 25
42.9%
32.9%
Q2 25
43.7%
22.1%
Q1 25
41.6%
52.4%
Q4 24
36.5%
91.1%
Q3 24
26.3%
Q2 24
22.5%
Q1 24
31.6%
Q4 23
24.7%
15.8%
Operating Margin
ICCC
ICCC
SMR
SMR
Q3 25
0.4%
-6532.9%
Q2 25
8.8%
-534.9%
Q1 25
13.9%
-264.1%
Q4 24
8.0%
-34.6%
Q3 24
-9.6%
Q2 24
-25.3%
Q1 24
-4.1%
Q4 23
-19.7%
-1558.2%
Net Margin
ICCC
ICCC
SMR
SMR
Q3 25
-2.5%
-3316.2%
Q2 25
7.8%
-219.0%
Q1 25
17.9%
-104.7%
Q4 24
-219.1%
Q3 24
-11.7%
Q2 24
-28.0%
Q1 24
-6.0%
Q4 23
-411.3%
EPS (diluted)
ICCC
ICCC
SMR
SMR
Q3 25
$-0.02
$-1.85
Q2 25
$0.06
$-0.13
Q1 25
$0.16
$-0.11
Q4 24
$0.09
$-0.77
Q3 24
$-0.09
Q2 24
$-0.20
Q1 24
$-0.06
Q4 23
$-0.15
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICCC
ICCC
SMR
SMR
Cash + ST InvestmentsLiquidity on hand
$3.9M
$691.8M
Total DebtLower is stronger
$9.5M
Stockholders' EquityBook value
$29.8M
$828.7M
Total Assets
$45.7M
$883.1M
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICCC
ICCC
SMR
SMR
Q3 25
$3.9M
$691.8M
Q2 25
$420.7M
Q1 25
$521.4M
Q4 24
$3.8M
$441.6M
Q3 24
Q2 24
$1.3M
Q1 24
$960.3K
Q4 23
$978.7K
$120.3M
Total Debt
ICCC
ICCC
SMR
SMR
Q3 25
$9.5M
Q2 25
Q1 25
$8.7M
Q4 24
$9.0M
Q3 24
$9.4M
Q2 24
$9.8M
Q1 24
$10.2M
Q4 23
$10.5M
Stockholders' Equity
ICCC
ICCC
SMR
SMR
Q3 25
$29.8M
$828.7M
Q2 25
$29.9M
$692.9M
Q1 25
$29.0M
$704.0M
Q4 24
$27.5M
$618.7M
Q3 24
$26.4M
Q2 24
$23.5M
Q1 24
$24.6M
Q4 23
$25.0M
$93.5M
Total Assets
ICCC
ICCC
SMR
SMR
Q3 25
$45.7M
$883.1M
Q2 25
$46.7M
$606.5M
Q1 25
$45.6M
$618.1M
Q4 24
$45.1M
$544.7M
Q3 24
$44.4M
Q2 24
$41.9M
Q1 24
$43.1M
Q4 23
$43.8M
$224.9M
Debt / Equity
ICCC
ICCC
SMR
SMR
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.33×
Q3 24
0.36×
Q2 24
0.42×
Q1 24
0.41×
Q4 23
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICCC
ICCC
SMR
SMR
Operating Cash FlowLast quarter
$-1.2M
$-199.8M
Free Cash FlowOCF − Capex
$-1.8M
$-199.9M
FCF MarginFCF / Revenue
-32.3%
-2425.1%
Capex IntensityCapex / Revenue
10.8%
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$715.4K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICCC
ICCC
SMR
SMR
Q3 25
$-1.2M
$-199.8M
Q2 25
$1.6M
$-33.3M
Q1 25
$1.6M
$-22.8M
Q4 24
$-3.1K
$-26.4M
Q3 24
$-639.3K
Q2 24
$581.8K
Q1 24
$418.5K
Q4 23
$-723.1K
$-73.2M
Free Cash Flow
ICCC
ICCC
SMR
SMR
Q3 25
$-1.8M
$-199.9M
Q2 25
$1.4M
Q1 25
$1.2M
$-22.9M
Q4 24
$-199.3K
$-26.5M
Q3 24
$-727.7K
Q2 24
$471.0K
Q1 24
$348.1K
Q4 23
$-804.4K
$-73.3M
FCF Margin
ICCC
ICCC
SMR
SMR
Q3 25
-32.3%
-2425.1%
Q2 25
22.4%
Q1 25
15.4%
-170.9%
Q4 24
-2.6%
-77.3%
Q3 24
-12.1%
Q2 24
8.6%
Q1 24
4.8%
Q4 23
-15.8%
-1606.6%
Capex Intensity
ICCC
ICCC
SMR
SMR
Q3 25
10.8%
0.9%
Q2 25
2.4%
Q1 25
4.1%
0.5%
Q4 24
2.5%
0.1%
Q3 24
1.5%
Q2 24
2.0%
Q1 24
1.0%
Q4 23
1.6%
1.1%
Cash Conversion
ICCC
ICCC
SMR
SMR
Q3 25
Q2 25
3.19×
Q1 25
1.09×
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ICCC
ICCC

Segment breakdown not available.

SMR
SMR

Power Plant And NPM Engineering Design And Licensing Services And Fees$8.0M97%
Other$208.0K3%

Related Comparisons